Form 4: Daxor Corp CEO Michael Feldschuh Increases Stake in Company
SEC Form 4 Filing
Daxor Corp's CEO, Michael Richard Feldschuh, acquired 647 shares of Daxor Common Stock at $8.15 per share on March 19, 2024, increasing his direct holdings to 209,631 shares.
Summary
- On March 19, 2024, Michael Richard Feldschuh, the CEO of Daxor Corp, purchased 647 shares of Daxor Common Stock.
- The purchase price was $8.15 per share.
- Following this transaction, Feldschuh directly owns 209,631 shares of Daxor Common Stock.
Sentiment
Score: 7
Explanation: The sentiment is moderately positive due to the CEO's purchase of company stock, indicating confidence in the company's prospects.
Positives
- The CEO's purchase of shares may signal confidence in the company's future prospects.
Industry Context
Insider buying is often seen as a positive sign, suggesting that a company's leadership believes the stock is undervalued.
Stakeholder Impact
- Shareholders may view the CEO's purchase as a positive signal.
- The increased stake of the CEO aligns his interests more closely with those of other shareholders.
Key Dates
| Date | Description |
|---|---|
| 03/19/2024 | Date of transaction: Michael Feldschuh purchased 647 shares of Daxor Common Stock. |
| 03/20/2025 | Date of signature on the report. |
Keywords
Daxor Corp, Michael Feldschuh, Insider Trading, Share Acquisition, Form 4, DXR, Ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.